Anti-Toxoplasma antibodies in Egyptian rheumatoid arthritis patients

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Rheumatology International

• Publication date

  2017-03-20

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s00296-017-3703-8PMID 28321492
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cerebral toxoplasmosis and anti-TNFα: a case report

  2016cited by this paper
• The current status of Toxoplasma gondii infection among Egyptian rheumatoid arthritis patients

  2016cited by this paper
• Severe leukopenia in a rheumatoid arthritis patient treated with a methotrexate/leflunomide combination.

  2014cited by this paper
• Toxoplasmosis – A Global Threat. Correlation of Latent Toxoplasmosis with Specific Disease Burden in a Set of 88 Countries

  2014cited by this paper
• Leucopenia grave em paciente com artrite reumatoide tratada com combinação de metotrexato e leflunomida

  2014cited by this paper
• Detection of Toxoplasma Antibodies and TNF-α in Rheumatoid Arthritis Patients Treated with Methotrexate

  2014cited by this paper
• Cerebral toxoplasmosis following adalimumab treatment in rheumatoid arthritis.

  2014cited by this paper
• Toxoplasma gondii: bystander or cofactor in rheumatoid arthritis

  2013cited by this paper
• Prevalence of anti-Toxoplasma antibodies in patients with autoimmune diseases.

  2012cited by this paper
• 2012 Update of the 2008 American College of Rheumatology recommendations for the use of disease‐modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis

  2012cited by this paper
• The pathogenesis of rheumatoid arthritis.

  2011cited by this paper
• [Acute toxoplasmosis infection in a patient with ankylosing spondylitis treated with adalimumab: a case report].

  2011cited by this paper
• One target, different effects: a comparison of distinct therapeutic antibodies against the same targets

  2011cited by this paper
• Defining and analyzing geoepidemiology and human autoimmunity.

  2010cited by this paper
• UvA-DARE (Digital Academic Repository) 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative Aletaha,

  2010cited by this paper
• Toxoplasma gondii: determinants of tachyzoite to bradyzoite conversion

  2010cited by this paper
• High Prevalence of Toxoplasmosis in Cats from Egypt: Isolation of Viable Toxoplasma gondii, Tissue Distribution, and Isolate Designation

  2010cited by this paper
• Anti-retinal autoantibodies in experimental ocular and systemic toxoplasmosis

  2010cited by this paper
• 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative.

  2010cited by this paper
• Toxoplasma seroprevalence in a rural population in France: detection of a household effect

  2009cited by this paper
• Spontaneous arthritis in MRL/lpr mice is aggravated by Staphylococcus aureus and ameliorated by Nippostrongylus brasiliensis infections

  2009cited by this paper
• Schistosoma mansoni infection reduces severity of collagen-induced arthritis via down-regulation of pro-inflammatory mediators.

  2009cited by this paper
• Infectious Serologies and Autoantibodies in Inflammatory Bowel Disease

  2009cited by this paper
• Seroprevalence of and risk factors for Toxoplasma gondii antibodies among asymptomatic blood donors in Egypt

  2009cited by this paper
• Interplay of parasite-driven immune responses and autoimmunity.

  2008cited by this paper
• Infectious Complications with Anti-TNFα Therapy in Rheumatic Diseases: A Review

  2007cited by this paper
• Infectious complications with anti-TNFalpha therapy in rheumatic diseases: a review.

  2007cited by this paper
• Toxoplasmic chorioretinitis and antitumor necrosis factor treatment in rheumatoid arthritis.

  2007cited by this paper
• Is there any relationship between toxoplasma infection and reactive arthritis?

  2007cited by this paper
• The pathogenesis of rheumatoid arthritis.

  2007cited by this paper
• Leishmaniasis, Autoimmune Rheumatic Disease, and Anti–Tumor Necrosis Factor Therapy, Europe

  2006cited by this paper
• Methotrexate and oral ulceration

  2005cited by this paper
• Infliximab and reactivation of cerebral toxoplasmosis.

  2005cited by this paper
• Reactivation of latent granulomatous infections by infliximab.

  2005cited by this paper
• Combination of infliximab and methotrexate therapy for early rheumatoid arthritis: a randomized, controlled trial.

  2004cited by this paper
• Helminths and harmony

  2003cited by this paper
• Evolving concepts of rheumatoid arthritis

  2003cited by this paper
• Adalimumab, a fully human anti-tumor necrosis factor alpha monoclonal antibody, for the treatment of rheumatoid arthritis in patients taking concomitant methotrexate: the ARMADA trial.

  2003cited by this paper
• Rheumatoid arthritis measures: Disease activity score (DAS), disease activity score-28 (DAS28), rapid assessment of disease activity in rheumatology (RADAR), and rheumatoid arthritis disease activity index (RADAI)

  2003cited by this paper
• Pathogenesis of Chagas heart disease: role of autoimmunity.

  2002cited by this paper
• Oral infection of C57BL/6 mice with Toxoplasma gondii: a new model of inflammatory bowel disease?

  2002cited by this paper
• Rheumatoid Arthritis and Immune Thrombocytopenia: A Report of Two Cases

  2002cited by this paper
• Etanercept therapy in rheumatoid arthritis. A randomized, controlled trial.

  1999cited by this paper
• Infliximab (chimeric anti-tumour necrosis factor alpha monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial. ATTRACT Study Group.

  1999cited by this paper
• Infliximab (chimeric anti-tumour necrosis factor α monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial

  1999cited by this paper
• Etanercept Therapy in Rheumatoid Arthritis

  1999cited by this paper
• Association of CD4+ T cell-dependent, interferon-gamma-mediated necrosis of the small intestine with genetic susceptibility of mice to peroral infection with Toxoplasma gondii

  1996cited by this paper
• Infection rate and use of antibiotics in patients with rheumatoid arthritis treated with methotrexate.

  1994cited by this paper
• The shared epitope hypothesis. An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis.

  1987cited by this paper

• Association of infection with Toxoplasma gondii and arthritis: Insights from a cross-sectional study and genetic epidemiology analysis.

  2025cites this paper
• Parasitic helminths and protozoa: Treasure boxes of disease modifying anti-rheumatic drugs.

  2024cites this paper
• A case-control study of the association of toxoplasmosis with antirheumatic therapy in rheumatoid arthritis

  2024cites this paper
• Association between toxoplasmosis and autoimmune rheumatic diseases in Egyptian patients.

  2023cites this paper
• Vaccination with Toxoplasma lysate antigen or its encapsulated niosomes form immunomodulates adjuvant-induced arthritis through JAK3 downregulation

  2023cites this paper
• Toxoplasma and Toxocara seropositivity in juvenile idiopathic arthritis and its relation to disease activity and type of therapies

  2023cites this paper
• Seropositivity of Toxoplasma gondii antibodies in rheumatoid arthritis patients under treatment with TNF-? antagonists

  2022cites this paper
• Development of Rheumatoid Arthritis by Toxoplasmosis in Iranian Patients

  2021cites this paper
• Impact of Toxoplasma gondii infection on human health

  2021cites this paper
• Role of Interleukin 33 During Infection with Toxoplasmosis in Rheumatoid Arthritis Patients

  2020influential citation
• Exposure to toxoplasmosis among the Egyptian population: A systematic review

  2020cites this paper
• Seroprevalence of Toxoplasma Gondii in Saudi Autoimmune Disease Patients

  2019cites this paper
• Особливості кальцієво-фосфорного обміну й стану кісток у хворих на ревматоїдний артрит: патоґенез, діаґностика та принципи диференційованого лікування

  2019cites this paper
• Toxoplasma gondii Infection Delays the Onset and Decreases the Severity of Rheumatoid Arthritis in a Programmed Death-1 Mediated Mechanism

  2019cites this paper
• Possible Critical Role of Latent Chronic Toxoplasma Gondii Infection in Triggering, Development and Persistence of Autoimmune Diseases

  2018cites this paper
• Toxoplasmosis seroprevalence in rheumatoid arthritis patients: A systematic review and meta-analysis

  2018cites this paper
• The autoimmune ecology: an update

  2018cites this paper
• One year in review 2018: pathogenesis of rheumatoid arthritis.

  2018cites this paper
• Seroprevalence of Toxoplasma gondii infection in arthritis patients in eastern China

  2017cites this paper